NCT02511535View on ClinicalTrials.gov

TBE (Tick-borne Encephalitis) Vaccination in Allergic Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

119

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

February 29, 2016

Study Completion Date

September 30, 2016

Conditions
Vaccine Responsiveness in AllergyVaccine Responsiveness During Allergy De-sensitization Treatment
Interventions
BIOLOGICAL

TBE booster vaccination

Trial Locations (1)

1090

Medical University Vienna, Institute of Specific Prophylaxis and Tropical Medicine, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT02511535 - TBE (Tick-borne Encephalitis) Vaccination in Allergic Patients | Biotech Hunter | Biotech Hunter